Alexa: Tell me about Amazon’s ambitions in healthcareOver the last two years Amazon’s healthcare plans have gone from being a closely guarded secret to underpinning Share XAlexa: Tell me about Amazon’s ambitions in healthcarehttps://pharmaphorum.com/digital/amazon-alexa-haven-healthcare/
Abilify MyCite and innovating in digital healthpharmaphorum’s Paul Tunnah spoke with Otsuka Pharmaceutical’s North America Pharmaceutical Business president and CEO Kabir Nath about the Share XAbilify MyCite and innovating in digital healthhttps://pharmaphorum.com/views-analysis-digital/abilify-mycite-and-innovating-in-digital-health/
GSK and digital disruption: the pharmaphorum podcastDigital innovation and disruption in healthcare are the subject of this episode of the pharmaphorum podcast, for which Share XGSK and digital disruption: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gsk-digital-disruption
Pharma must put patients at the centre of the shift to value-based careThe pharma industry has been talking about the healthcare sector’s move to value-based care for some time. Even Share XPharma must put patients at the centre of the shift to value-based carehttps://pharmaphorum.com/views-analysis-patients/pharma-must-put-patients-at-the-centre-of-the-shift-to-value-based-care/
Digital health round-up: Expert team prepares for digital transformation of NHS and moreEngland’s NHS is gearing up towards the ‘go live’ of a new digital transformation team that aims to Share XDigital health round-up: Expert team prepares for digital transformation of NHS and morehttps://pharmaphorum.com/views-analysis-digital/digital-health-round-up-expert-team-prepares-for-digital-transformation-of-nhs-and-more/
Getting inspired at South by SouthwestFollowing this year’s South by Southwest (SXSW) conference in Austin, Texas, it occurred to me that the progression Share XGetting inspired at South by Southwesthttps://pharmaphorum.com/views-analysis-sales-marketing/getting-inspired-at-south-by-southwest/
Eyeforpharma Barcelona 2019 roundupThis year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting Share XEyeforpharma Barcelona 2019 rounduphttps://pharmaphorum.com/digital/eyeforpharma-barcelona-2019-roundup/
No longer artificial – AI in pharma and healthcareEleven years is a long time to be writing about ‘digital pharma’, and I do indeed remember when Share XNo longer artificial – AI in pharma and healthcarehttps://pharmaphorum.com/views-and-analysis/ai-pharma-healthcare/
Challenging the idea of valid dataWhat is valid patient data? Industry colleagues and I recently wrestled with that question at the CBI Patient Share XChallenging the idea of valid datahttps://pharmaphorum.com/views-and-analysis/challenging-the-idea-of-valid-data/
